Biomedical, Clinical & Life Sciences

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
Applicants are only allowed to submit one proposal per organization. If more than one proposal is submitted from an organization, all proposals from that institution will be considered ineligible for funding.

Executive Summary
The Bureau of Emerging Threats (ET) leads the Department of State in anticipating and responding to national security challenges arising from adversary use of new technologies across cyberspace, outer space, critical infrastructure and undersea domains, quantum technologies, and artificial intelligence (AI). ET focuses on protecting U.S. national security in these areas of strategic and technological competition using diplomatic tools and interagency capabilities as part of coordinated foreign policy responses.

Within ET, the Office of Critical Infrastructure Security (ET/CI) is responsible for addressing novel threats and disruptions to critical infrastructure that threaten lives, economic stability, and national power. ET/CI addresses threat vectors targeting major critical infrastructure sectors, including energy systems, communications networks, transportation and logistics, financial systems, healthcare, and water, and works to coordinate “upgrade and secure” efforts with allies and partners, counter attacks against data centers, and protect against cloud security vulnerabilities.

In the Western Hemisphere, adversaries have exploited weak cyber defenses in government networks and critical infrastructure to gain intelligence advantages, potential coercive leverage over sovereign decision-making, and latent access pathways that may extend to U.S. interests. Argentina, under the Milei administration, has signaled that it seeks close alignment with the United States on strategic and economic issues, including a deliberate transition away from untrusted foreign digital infrastructure suppliers in favor of trusted, market-oriented partners.

Persistent and sophisticated cyber threats—including advanced persistent threats (APTs), targeted ransomware, and espionage campaigns—continue to target Argentine ministries and critical infrastructure. Without a mature national-level Security Operations Center (SOC) with clear authorities, mission, charter, and well-trained staff, a country’s ability to detect, analyze, and respond to such threats in a coordinated manner remains limited.

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language
Duplicate or Multiple Submissions – Only one application will be accepted from each organization or institution. NIFA will accept the most recent application if an applicant submits duplicate or multiple submissions.

Executive Summary
NIFA requests applications for the OAVFR program for FY 2026 to encourage and assist farmers and ranchers with owning and operating farms and ranches and accessing the full range of agricultural, forestry, and related programs offered by USDA. The amount for awards in FY 2026 is approximately $23,800,000. This notice identifies the objectives for OAVFR program projects, deadlines, funding information, eligibility criteria for projects and applicants, and application forms and associated instructions.

Limit: 1 // Tickets Available: 0

J. Parlin (Cooperative Extension)

Limiting Language
Only one proposal per organization will be accepted in the grants cycle.

Overview
The Delta Dental of Arizona Foundation (DDAZF) Grant Program supports projects and services promoting good oral health/vision practices, increasing access to dental/vision care, nutrition programs, food banks and pantries.

It is the intention that this funding will:

• Encourage and advance the integration of oral health and overall health.
• Increase access to oral health or vision services to underserved communities.
• Promote collaboration across a wide range of health providers in Arizona.
• Increase use of proven approaches into greater and more widespread practice.
• Increase food security.
• Improve nutritional quality of available food.
• Increase nutrition awareness.

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language 
Only one application per institution (normally identified by having a unique entity identifier (UEI) number or NIH IPF number) is allowed

Purpose
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on novel therapies for adult glioblastoma (GBM). The goal is to improve the treatment of adult GBM by developing novel effective agents that can cross the blood brain barrier (BBB) and testing them clinically. Successful early-stage trials of new drugs from this NOFO would transition seamlessly to later stage trials using well-established NCI clinical trial mechanisms.

To implement this concept, a highly collaborative GBM Therapeutics Network (GTN) of cross-cutting teams will be established, each team capable of driving therapeutic agent(s) from pre-clinical development, through investigational new drugs (IND) studies, into pilot clinical studies in humans. Appropriate therapeutic agents include: (1) novel agents or (2) agents or combinations approved for other indications and repurposed for treatment of GBM following appropriate preclinical studies. The scope of the NOFO, from late pre-clinical through early (Phase 0/1) clinical studies, uniquely spans a gap in the GBM drug development process.

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
Applicant organizations may submit only one application.

Purpose
The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications for Centers within the NIDDK Cooperative Centers of Experimental in Hematology (CCEH) Program. Each Center will support one to three Biomedical Research Cores and an Administrative Core, including an Enrichment Program. Each Center is expected to work collaboratively with NIDDK, the Hematology Coordinating Center (HCC), and the other CCEH Centers. The CCEH Program is designed to increase access to critical research resources and expertise unique to nonmalignant hematology research. By providing innovative technology, resources, and expertise to the greater hematology research community, the program will serve as a national hub, aimed at recruiting and retaining both junior scientists just beginning their careers in the field as well as established investigators from other domains.

Limit: 1 // Tickets Available: 0 

S. Dahmer (Andrew Weil Center for Integrative Medicine)

Limiting Language
Only one entry per institution is permitted, either as an individual entry or as a partnership entry with other institution(s). Two or more institutions that have formed close collaborations to enhance nutrition education across the institutions may submit to this Challenge as a partnership.

Overview
The National Institutes of Health (NIH) Office of Nutrition Research (ONR) announces the “Integration of Nutrition Training into Health Care Education” Challenge. ONR’s mission is to stimulate innovative research to address the complexities of nutrition, its ecology, and its critical role in health across the lifespan for all. The goal of this challenge is to identify, evaluate, and promote effective, scalable, and evidence-based approaches to integrating nutrition training into medical and nursing education, including both established programs and emerging models with strong potential for dissemination. The total prize purse from NIH for this Challenge is up to $2,100,000.

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
An individual applicant may not submit more than one application in response to this NOFO and may not be offered more than one award.

Executive Summary
The U.S. Department of Agriculture, Foreign Agricultural Service announces this notice of funding opportunity (NOFO) to support the Assisting Specialty Crop Exports (ASCE) Initiative by issuing a new award. The award is contingent on the availability of funding. This initiative aims to enhance U.S. specialty crop market access in key export markets and support producers with cost-effective approaches for post-harvest pest control and maintaining quality during storage and export. This opportunity is available to U.S. academic institutions, nonprofits with or without 501(c)(3) designation, U.S. trade associations, U.S. agricultural cooperatives, international organizations based in the United States, and any other United State-based entity including private sector businesses. The award is intended to assist U.S. tree nut and durable specialty crop producers and agribusinesses by developing the processes and technologies for phytosanitary validation and traceability of low-oxygen storage and packaging systems. Applicants must be registered in SAM.gov and apply through USDA’s ezFedGrants online system, both of which require an identity-proofed login.gov account. 

Benefits to the United States: 

• This program makes America more prosperous by strengthening trade. 
• This program makes America more prosperous by expanding and developing new markets in current and potential trading partners.

Request Ticket (Include Component) // Limit: 2 (Component A or B) // Tickets Available: 2

Limiting Language
You must follow these limits on the number of applications your organization can submit.

You may apply to either Component A or Component B, or both. Each organization (normally identified by having a unique UEI number) may submit one application for each component. So, at the most, you may submit two applications.

Summary
This NOFO has two funding components:

• Component A: National Spina Bifida Patient Registry (NSBPR).
• Component B: Urologic Management to Preserve Initial Renal Function Protocol for Young Children with Spina Bifida (UMPIRE).

The purpose of this NOFO is to:

• Component A: Collect high-quality longitudinal data on children and adults with spina bifida (SB) who get care in specialized SB clinics that are part of the National Spina Bifida Patient Registry (NSBPR).
• Component B: Carry out and evaluate the Urologic Management to Preserve Initial Renal Function Protocol for Young Children with Spina Bifida (UMPIRE) iterative protocol in infants and young children with myelomeningocele. Building on existing longitudinal data collection, recipients will collect and analyze data on patients with SB to:
  • Better understand health outcomes after interventions and treatments.
  • Share findings to identify opportunities to improve care of patients with SB.

You may apply to either Component A or Component B, or both.

Institutionally Coordinated // Limit: 1

Limiting Language
Only one application per institution (identified by NIH IPF number) is allowed.

Funding Opportunity Purpose
This Notice of Funding Opportunity (NOFO) solicits applications to develop shared-use research facilities or research-supporting facilities that enable collaborative research and benefit broad research communities at large. The NOFO supports two existing construction programs: the Biomedical Research Facilities (BRF) program and the HIV/AIDS Research Facilities (HRF) program.

The BRF program supports the construction or modernization of biomedical research facilities that advance basic, translational, clinical, or behavioral science research in all areas. Intended facilities include shared research spaces, core facilities, biorepositories, or other shared-use resource facilities that serve a broad scientific community with a significant, long-term impact on biomedical research.

The HRF program funds the development of HIV/AIDS research or research-supporting resources that the empowered research activities must align with the NIH Office of AIDS Research (OAR) priorities, as outlined at OAR HIV/AIDS Research Priorities, including research focusing on the long-term health consequences of HIV infection.

NIH encourages applications from institutions across all geographic regions of the country, including Institutions of Emerging Excellence (IEE) in biomedical research, to strengthen the nation’s research capacity.

Request Ticket // Limit: 1* (additional application possible for cancer types specified below) // Tickets Available: 1

Limiting Language

• Each institution may submit one (1) LOI/application in each open St. Baldrick’s funding category. 
• ATTENTION:  St. Baldrick’s Foundation has identified the areas below as funding interests and has donors interested in supporting meritorious projects in these areas. To encourage submissions in these priority areas, institutions may submit one additional LOI beyond the standard limited submissions. Only one additional submission is permitted per institution for the entire cycle (Research, Scholar, International Scholar or Survivorship & Supportive Care Research Grant); this does not allow one additional submission in each program or funding category. 
  • Brain tumors – all types, including rare forms, especially atypical teratoid/rhabdoid tumor (AT/RT), diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG), and glioblastoma (GBM) 
  • Burkitt lymphoma – all types, especially sporadic 
  • Rhabdoid tumors - Extrarenal 
• Applications submitted in the above funding interest areas will be considered in a separate study section. 

Program Overview
These grants are for specific two-year research projects which are hypothesis driven and may be either laboratory, clinical, or epidemiological in nature. Please submit a realistic budget for the project. Grants will be $100,000/year or less, for two years.